Orgenesis to Present Today at the Winter Wonderland Conference-Best Ideas from the Buy-Side

Rhea-AI Summary

Orgenesis Inc. (NASDAQ: ORGS) announced its participation in the Winter Wonderland Conference hosted by The MicroCap Rodeo from February 16-19, 2021. CEO Vered Caplan is scheduled to present on February 16 at 2:30 PM Eastern Time, with a live webcast available. The conference features top investment ideas with one-on-one meetings for institutional investors on February 18-19. Orgenesis focuses on developing affordable cell and gene therapies through its POCare Platform, enabling scalable production at the point of care.

GERMANTOWN, Md., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will be presenting at the Winter Wonderland Conference, hosted by The MicroCap Rodeo, being held virtually on February 16^th - February 19^th, 2021.

Vered Caplan, CEO of Orgenesis, is scheduled to present today, February 16th, 2021 at 2:30 PM, Eastern Time. The presentation will be webcast live and available for replay here. One-on-one meetings will be held throughout the conference via video conference calls.

About the Winter Wonderland Conference
The MicroCap Rodeo is hosting its “Winter Wonderland Conference- Best Ideas Bowl,” with 25-minute virtual presentations from the 16th to 17th, and one-on-ones for qualified institutional investors on the 18th and 19^th. This conference is a virtual conference that brings you the top 25 best ideas from the buy side. Qualified institutional investors recommended each of the 25 companies represented as one of their best ideas. For more information, please visit the event website: https://microcaprodeo.com/.

About Orgenesis
Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The POCare Network brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies. Learn more about the work Orgenesis is doing at www.orgenesis.com.

Contact for Orgenesis:
David Waldman
Crescendo Communications, LLC
Tel: 212-671-1021

 

FAQ

What is the date of Orgenesis' presentation at the Winter Wonderland Conference?

Orgenesis' presentation is scheduled for February 16, 2021.

What time will Orgenesis present at the Winter Wonderland Conference?

The presentation will take place at 2:30 PM Eastern Time.

Where can I watch the Orgenesis presentation from the Winter Wonderland Conference?

The presentation will be webcast live and available for replay on their official channels.

What is the focus of Orgenesis as a biotech company?

Orgenesis works on unlocking the potential of cell and gene therapies through its POCare Platform.

How long is the Winter Wonderland Conference?

The Winter Wonderland Conference runs from February 16 to February 19, 2021.